Novo Nordisk raises expectations for Eli Lilly after CagriSema slipup
Novo Nordisk (NVO) increased valuation gap with Eli Lilly (LLY) after its Phase 3 data for next-gen weight loss drug ...
Novo Nordisk stock price takes a tumble after the Wegovy maker’s next-generation weight-loss drug underwhelms
Results for its new CagriSema drug, while promising, fell below expectations, sending shares of the pharmaceutical giant down ...
Japan Today15h
Weight-loss drugs draw Americans back to the doctor
Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...
ABC News12h
Political News
The president-elect made the announcement on Truth Social on Sunday. ABC News’ MaryAlice Parks discusses President Joe Biden's invitation for President-elect Donald Trump to visit the White ...